Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 44.

Harlander, Sabine; Schönenberger, Désirée; Toussaint, Nora C; Prummer, Michael; Catalano, Antonella; Brandt, Laura; Moch, Holger; Wild, Peter J; Frew, Ian J (2017). Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice. Nature Medicine, 23(7):869-877.

Corrò, Claudia; Hejhal, Tomas; Poyet, Cédric; Sulser, Tullio; Hermanns, Thomas; Winder, Thomas; Prager, Gerald; Wild, Peter J; Frew, Ian; Moch, Holger; Rechsteiner, Markus (2017). Detecting circulating tumor DNA in renal cancer: An open challenge. Experimental and Molecular Pathology, 102(2):255-261.

Zhong, Qing; Guo, Tiannan; Rechsteiner, Markus; Rüschoff, Jan H; Rupp, Niels; Fankhauser, Christian; Saba, Karim; Mortezavi, Ashkan; Poyet, Cédric; Hermanns, Thomas; Zhu, Yi; Moch, Holger; Aebersold, Ruedi; Wild, Peter J (2017). A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients. Scientific Data, 4:170014.

Noske, Aurelia; Brandt, Simone; Valtcheva, Nadejda; Wagner, Ulrich; Zhong, Qing; Bellini, Elisa; Fink, Daniel; Obermann, Ellen C; Moch, Holger; Wild, Peter J (2017). Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer. OncoTarget, 8(9):14794-14805.

Strand, Siri H; Switnicki, Michal; Moller, Mia; Haldrup, Christa; Storebjerg, Tine M; Hedegaard, Jakob; Nordentoft, Iver; Hoyer, Soren; Borre, Michael; Pedersen, Jakob S; Wild, Peter J; Park, Jong Y; Orntoft, Torben F; Sorensen, Karina D (2017). RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy. OncoTarget, 8(4):5774-5788.

Valtcheva, Nadejda; Lang, Franziska M; Noske, Aurelia; Samartzis, Eleftherios P; Schmidt, Anna-Maria; Bellini, Elisa; Fink, Daniel; Moch, Holger; Rechsteiner, Markus; Dedes, Konstantin J; Wild, Peter J (2017). Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report. BMC Cancer, 17(1):1-9.

Velizheva, Nadezda P; Rechsteiner, Markus P; Wong, Christine E; Zhong, Qing; Rössle, Matthias; Bode, Beata; Moch, Holger; Soltermann, Alex; Wild, Peter J; Tischler, Verena (2017). Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung. Cancer Cytopathology, 125(1):30-40.

Weyerer, Veronika; Schneckenpointner, Roland; Filbeck, Thomas; Burger, Maximilian; Hofstaedter, Ferdinand; Wild, Peter J; Fine, Samson W; Humphrey, Peter A; Dehner, Louis P; Amin, Mahul B; Rüschoff, Josef; Boltze, Carsten; Tannapfel, Andrea; Zwarthoff, Ellen; Lopez-Beltran, Antonio; Montironi, Rodolfo; Langner, Cord; Stoehr, Robert; Hartmann, Arndt; Giedl, Johannes (2017). Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years. Journal of Cancer, 8(3):1-9.

Groner, Anna C; Cato, Laura; de Tribolet-Hardy, Jonas; Bernasocchi, Tiziano; Janouskova, Hana; Melchers, Diana; Houtman, René; Cato, Andrew C B; Tschopp, Patrick; Gu, Lei; Corsinotti, Andrea; Zhong, Qing; Fankhauser, Christian; Fritz, Christine; Poyet, Cédric; Wagner, Ulrich; Guo, Tiannan; Aebersold, Ruedi; Garraway, Levi A; Wild, Peter J; Theurillat, Jean-Philippe; Brown, Myles (2016). TRIM24 is an oncogenic transcriptional activator in prostate cancer. Cancer Cell, 29(6):846-858.

Guinot, Anna; Lehmann, Holger; Wild, Peter J; Frew, Ian J (2016). Combined deletion of Vhl, Trp53 and Kif3a causes cystic and neoplastic renal lesions. Journal of Pathology, 239(3):365-373.

Mortezavi, Ashkan; Keller, Etienne Xavier; Poyet, Cédric; Hermanns, Thomas; Saba, Karim; Randazzo, Marco; Fankhauser, Christian Daniel; Wild, Peter J; Moch, Holger; Sulser, Tullio; Eberli, Daniel (2016). Clinical impact of prostate biopsy undergrading in an academic and community setting. World Journal of Urology, 34(10):1481-1490.

Schönenberger, Désirée; Harlander, Sabine; Rajski, Michal; Jacobs, Robert A; Lundby, Anne-Kristine; Adlesic, Mojca; Hejhal, Tomas; Wild, Peter J; Lundby, Carsten; Frew, Ian J (2016). Formation of renal cysts and tumors in Vhl/Trp53-deficient mice requires HIF-1α and HIF-2α. Cancer Research, 76(7):2025-2036.

Zhong, Qing; Rüschoff, Jan H; Guo, Tiannan; Gabrani, Maria; Schüffler, Peter J; Rechsteiner, Markus; Liu, Yansheng; Fuchs, Thomas J; Rupp, Niels J; Fankhauser, Christian; Buhmann, Joachim M; Perner, Sven; Poyet, Cédric; Blattner, Miriam; Soldini, Davide; Moch, Holger; Rubin, Mark A; Noske, Aurelia; Rüschoff, Josef; Haffner, Michael C; Jochum, Wolfram; Wild, Peter J (2016). Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity. Scientific Reports, 6:24146.

Störkel, Stephan; Wild, Peter J; Moch, Holger (2016). Nierentumoren im Erwachsenenalter. In: Amann, Kerstin; Kain, Renate; Klöppel, Günter. Pathologie. Berlin Heidelberg: Springer, 443-485.

Rupp, Niels J; Schüffler, Peter J; Zhong, Qing; Falkner, Florian; Rechsteiner, Markus; Rüschoff, Jan H; Fankhauser, Christian; Drach, Matthias; Largo, Remo; Tremp, Mathias; Poyet, Cedric; Sulser, Tullio; Kristiansen, Glen; Moch, Holger; Buhmann, Joachim; Müntener, Michael; Wild, Peter J (2016). Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer. Journal of Pathology Informatics, 7:3.

Umbehr, Martin H; Lüscher, Martin; Hunziker, Roger; Falkner, Florian; Wild, Peter J; Poyet, Cédric; Seifert, Burkhardt; Müntener, Michael (2015). Influence of Varying Assessment Parameters on the Diagnostic Accuracy of Magnetic Resonance Imaging in the Local Staging of Prostate Cancer. Urologia internationalis, 96(3):309-314.

Poyet, Cédric; Buser, Lorenz; Roudnicky, Filip; Detmar, Michael; Hermanns, Thomas; Mannhard, Doris; Höhn, Andrej; Rüschoff, Jan; Zhong, Qing; Sulser, Tullio; Moch, Holger; Wild, Peter J (2015). Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer. Journal of Clinical Pathology:online.

Albers, Joachim; Danzer, Claudia; Rechsteiner, Markus; Lehmann, Holger; Brandt, Laura P; Hejhal, Tomas; Catalano, Antonella; Busenhart, Philipp; Gonçalves, Ana Filipa; Brandt, Simone; Bode, Peter K; Bode-Lesniewska, Beata; Wild, Peter J; Frew, Ian J (2015). A versatile modular vector system for rapid combinatorial mammalian genetics. Journal of Clinical Investigation, 125(4):1603-1619.

Gaisa, Nadine T; Wilms, Holger; Wild, Peter J; Jakse, Gerhard; Heidenreich, Axel; Knuechel, Ruth (2015). In cystectomy specimens with bladder cancer whole organ embedding increases the detection rate of histopathological parameters, but not of those with prognostic significance. Virchows Archiv, 466(4):423-432.

Lehmann, Holger; Vicari, Daniele; Wild, Peter J; Frew, Ian J (2015). Combined deletion of Vhl and Kif3a accelerates renal cyst formation. Journal of the American Society of Nephrology (JASN), 26(11):2778-2788.

Sah, Bert-Ram; Burger, Irene A; Schibli, Roger; Friebe, Matthias; Dinkelborg, Ludger; Graham, Keith; Borkowski, Sandra; Bacher-Stier, Claudia; Valencia, Ray; Srinivasan, Ananth; Hany, Thomas F; Mu, Linjing; Wild, Peter J; Schaefer, Niklaus G (2015). Dosimetry and First Clinical Evaluation of the New 18F-Radiolabeled Bombesin Analogue BAY 864367 in Patients with Prostate Cancer. Journal of Nuclear Medicine, 56(3):372-378.

Church, David N; Stelloo, Ellen; Nout, Remi A; Valtcheva, Nadejda; Depreeuw, Jeroen; Ter Haar, Natalja; Noske, Aurelia; Amant, Frederic; Tomlinson, Ian P M; Wild, Peter J; Lambrechts, Diether; Jürgenliemk-Schulz, Ina M; Jobsen, Jan J; Smit, Vincent T H B M; Creutzberg, Carien L; Bosse, Tjalling (2015). Prognostic significance of POLE proofreading mutations in endometrial cancer. Journal of the National Cancer Institute, 107(1):1-8.

Ikenberg, Kristian; Valtcheva, Nadejda; Brandt, Simone; Zhong, Qing; Wong, Christine E; Noske, Aurelia; Rechsteiner, Markus; Rueschoff, Jan H; Caduff, Rosmarie; Dellas, Athanassios; Obermann, Ellen; Fink, Daniel; Fuchs, Thomas; Krek, Wilhelm; Moch, Holger; Frew, Ian J; Wild, Peter J (2014). KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. Journal of Pathology, 234(2):239-252.

Poyet, Cédric; Jentsch, Bastian; Hermanns, Thomas; Schweckendiek, Daniel; Seifert, Hans-Helge; Schmidtpeter, Martin; Sulser, Tullio; Moch, Holger; Wild, Peter J; Kristiansen, Glen (2014). Expression of histone deacetylases 1,2 and 3 in urothelial bladder cancer. BMC Clinical Pathology, 14:10.

Giesen, Charlotte; Wang, Hao A O; Schapiro, Denis; Zivanovic, Nevena; Jacobs, Andrea; Hattendorf, Bodo; Schüffler, Peter J; Grolimund, Daniel; Buhmann, Joachim M; Brandt, Simone; Varga, Zsuzsanna; Wild, Peter J; Günther, Detlef; Bodenmiller, Bernd (2014). Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nature Methods, 11(4):417-22.

Kristensen, Helle; Haldrup, Christa; Strand, Siri; Mundbjerg, Kamilla; Mortensen, Martin M; Thorsen, Kasper; Ostenfeld, Marie Stampe; Wild, Peter J; Arsov, Christian; Goering, Wolfgang; Visakorpi, Tapio; Egevad, Lars; Lindberg, Johan; Grönberg, Henrik; Høyer, Søren; Borre, Michael; Orntoft, Torben F; Sørensen, Karina D (2014). Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy. Clinical Cancer Research, 20(8):2169-2181.

Rechsteiner, Markus; Müller, Rouven; Reineke, Tanja; Goede, Jeroen; Bohnert, Annette; Zhong, Qing; Manz, Markus G; Moch, Holger; Wild, Peter J; Zimmermann, Dieter R; Tinguely, Marianne (2014). Modelling of a genetically diverse evolution of Systemic Mastocytosis with Chronic Myelomonocytic Leukemia (SM-CMML) by next generation sequencing. Experimental Hematology & Oncology, 3:18.

Theurillat, Jean-Philippe P; Udeshi, Namrata D; Errington, Wesley J; et al; Wild, Peter J; Moch, Holger; Garraway, Levi A (2014). Prostate cancer: Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer. Science, 346(6205):85-89.

Blattner, Mirjam; Lee, Daniel J; O'Reilly, Catherine; Park, Kyung; MacDonald, Theresa Y; Khani, Francesca; Turner, Kevin R; Chiu, Ya-Lin; Wild, Peter J; Dolgalev, Igor; Heguy, Adriana; Sboner, Andrea; Ramazangolu, Sinan; Hieronymus, Haley; Sawyers, Charles; Tewari, Ashutosh K; Moch, Holger; Yoon, Ghil Suk; Known, Yong Chul; Andrén, Ove; Fall, Katja; Demichelis, Francecsa; Mosquera, Juan Miguel; Robinson, Brian D; Barbieri, Christopher E; Rubin, Mark A (2014). SPOP mutations in prostate cancer across demographically diverse patient cohorts. Neoplasia, 16(1):14-20.

Albers, Joachim; Rajski, Michal; Schönenberger, Désirée; Harlander, Sabine; Schraml, Peter; von Teichman, Adriana; Georgiev, Strahil; Wild, Peter J; Moch, Holger; Krek, Wilhelm; Frew, Ian J (2013). Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice. EMBO Molecular Medicine, 5(6):949-964.

Wild, Peter J; Zhong, Qing; Zimmermann, Dieter R; Rechsteiner, Markus; Fritz, Christine; Valtcheva, Nadejda; Moch, Holger (2013). Personalisierte Krebsmedizin und die Zukunft der Pathologie. info@onkologie, 6:9-12.

Templeton, Arnoud J; Dutoit, Valérie; Cathomas, Richard; Rothermundt, Christian; Bärtschi, Daniela; Dröge, Cornelia; Gautschi, Oliver; Borner, Markus; Fechter, Eva; Stenner, Frank; Winterhalder, Ralph; Müller, Beat; Schiess, Ralph; Wild, Peter J; Rüschoff, Jan H; Thalmann, George; Dietrich, Pierre-Yves; Aebersold, Ruedi; Klingbiel, Dirk; Gillessen, Silke (2013). Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08). European Urology, 64(1):150-158.

Zeh, Nina; Wild, Peter J; Bode, Peter K; Kristiansen, Glen; Moch, Holger; Sulser, Tullio; Hermanns, Thomas (2013). Retroperitoneal teratoma with somatic malignant transformation: A papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy. BMC Urology, 13:9.

Schüffler, Peter J; Fuchs, Thomas J; Ong, Cheng Soon; Wild, Peter J; Rupp, Niels J; Buhmann, Joachim M (2013). TMARKER: A free software toolkit for histopathological cell counting and staining estimation. Journal of Pathology Informatics, 4(Suppl):S2.

Rechsteiner, Markus; Zimmermann, Anne-Katrin; Wild, Peter J; Caduff, Rosmarie; von Teichman, Adriana; Fink, Daniel; Moch, Holger; Noske, Aurelia (2013). TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type. Experimental and Molecular Pathology, 95(2):235-241.

Rössle, Matthias; Sigg, Michèle; Rüschoff, Jan H; Wild, Peter J; Moch, Holger; Weber, Achim; Rechsteiner, Markus P (2013). Ultra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF (V600E) mutations in colorectal carcinoma. Virchows Archiv, 463(5):623-631.

Meyer, Stefanie; Fuchs, Thomas J; Bosserhoff, Anja K; Hofstädter, Ferdinand; Pauer, Armin; Roth, Volker; Buhmann, Joachim M; Moll, Ingrid; Anagnostou, Nikos; Brandner, Johanna M; Ikenberg, Kristian; Moch, Holger; Landthaler, Michael; Vogt, Thomas; Wild, Peter J (2012). A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS ONE, 7(6):e38222.

Sais, Giovanni; Wyler, Stephen; Hudolin, Tvrtko; Banzola, Irina; Mengus, Chantal; Bubendorf, Lukas; Wild, Peter J; Hirsch, Hans H; Sulser, Tullio; Spagnoli, Giulio C; Provenzano, Maurizio (2012). Differential patterns of Large Tumor Antigen specific immune responsiveness in patients with BK polyomavirus positive prostate cancer or benign prostatic hyperplasia. Journal of Virology, 86(16):8461-8471.

Barbieri, Christopher E; Baca, Sylvan C; Lawrence, Michael S; Demichelis, Francesca; Blattner, Mirjam; Theurillat, Jean-Philippe; White, Thomas A; Stojanov, Petar; Van Allen, Eliezer; Stransky, Nicolas; Nickerson, Elizabeth; Chae, Sung-Suk; Boysen, Gunther; Auclair, Daniel; Onofrio, Robert C; Park, Kyung; Kitabayashi, Naoki; Macdonald, Theresa Y; Sheikh, Karen; Vuong, Terry; Guiducci, Candace; Cibulskis, Kristian; Sivachenko, Andrey; Carter, Scott L; Saksena, Gordon; Voet, Douglas; Hussain, Wasay M; Ramos, Alex H; Winckler, Wendy; Redman, Michelle C; Ardlie, Kristin; Tewari, Ashutosh K; Mosquera, Juan Miguel; Rupp, Niels; Wild, Peter J; Moch, Holger; Morrissey, Colm; Nelson, Peter S; Kantoff, Philip W; Gabriel, Stacey B; Golub, Todd R; Meyerson, Matthew; Lander, Eric S; Getz, Gad; Rubin, Mark A; Garraway, Levi A (2012). Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nature Genetics, 44(6):685-689.

Soll, Christopher; Riener, Marc-Oliver; Oberkofler, Christian Eugen; Hellerbrand, Claus; Wild, Peter J; DeOliveira, Michelle L; Clavien, Pierre-Alain (2012). Expression of serotonin receptors in human hepatocellular cancer. Clinical Cancer Research, 18(21):5902-5910.

Mortezavi, Ashkan; Hermanns, Thomas; Seifert, Hans-Helge; Wild, Peter J; Schmid, Daniel M; Sulser, Tullio; Eberli, Daniel (2012). Intrafascial dissection significantly increases positive surgical margin and biochemical recurrence rates after robotic-assisted radical prostatectomy. Urologia Internationalis, 89:17-24.

Wild, Peter J; Ikenberg, Kristian; Fuchs, Thomas J; Rechsteiner, Markus; Georgiev, Strahil; Fankhauser, Niklaus; Noske, Aurelia; Roessle, Matthias; Caduff, Rosmarie; Dellas, Athanassios; Fink, Daniel; Moch, Holger; Krek, Wilhelm; Frew, Ian J (2012). p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans. EMBO Molecular Medicine, 4(8):808-824.

von Boehmer, Lotta; Keller, Lukas; Mortezavi, Ashkan; Provenzano, Maurizio; Sais, Giovanni; Hermanns, Thomas; Sulser, Tullio; Jungbluth, Achim A; Old, Lloyd J; Kristiansen, Glen; van den Broek, Maries; Moch, Holger; Knuth, Alexander; Wild, Peter J (2011). MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer. PLoS ONE, 6(7):e21366.

Hoffmann, Andreas-Claudius; Wild, Peter J; Leicht, Christina; Bertz, Simone; Danenberg, Kathleen D; Danenberg, Peter V; Stöhr, Robert; Stöckle, Michael; Lehmann, Jan; Schuler, Martin; Hartmann, Arndt (2010). MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. Neoplasia, 12(8):628-636.

This list was generated on Mon Sep 25 09:12:55 2017 CEST.